Anti-CD73 Antibodies | Invitrogen - Thermo Fisher Scientific
Choose from 1 of 91 CD73 antibodies, which have been validated in experiments with 662 publications and 717 images featured in our data gallery. Browse primary antibodies for WB, …
NT5E/CD73 (D7F9A) Rabbit mAb | Cell Signaling Technology
NT5E/CD73 (D7F9A) Rabbit mAb recognizes endogenous levels of total NT5E/CD73 protein. Human, Mouse, Rat. Monoclonal antibody is produced by immunizing animals with …
CD73 Monoclonal Antibody (7G2) (41-0200) - Thermo Fisher Scientific
CD73 (Ecto-5-prime-nucleotidase, 5-prime-ribonucleotide phosphohydrolase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, the preferred …
Anti-CD73 in cancer immunotherapy: awakening new …
Anti-CD73 antibodies offer a great promise to counteract cancer onset and development in combination with other therapies (i.e. anti-PD-1mAbs), but what is the appropriate timing, …
CD73 Monoclonal Antibody (AD2), PE (12-0739-42) - Thermo Fisher Scientific
Description: This AD2 monoclonal antibody reacts with human CD73, a 5'-ectonucleotidase that converts 5'-adenosine monophosphate to adenosine. CD73 is expressed on the surface of …
CD73 Antibody (D-12) | SCBT - Santa Cruz Biotechnology
2019年8月17日 · CD73 Antibody (D-12) is an IgG 1 κ mouse monoclonal CD73 antibody (also designated 5′-nucleotidase antibody, or NT5E antibody) that detects the CD73 protein of …
Safety and efficacy of the anti-CD73 monoclonal antibody (mAb ...
2021年5月28日 · Oleclumab, a human IgG1λ mAb, inhibits CD73 function and may increase antitumor immunity. Initial data from a Phase I, first-in-human, dose-escalation and expansion …
Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody …
We developed two novel series of CD73 antibody, Ab001/Ab002 and humanized version Hu001/Hu002, which demonstrated high CD73 binding affinity, potent enzyme inhibition, and …
Anti-CD73 antibody [4G6E3] (ab202122) - Abcam
Mouse Monoclonal CD73 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 13 publications. Immunogen corresponding to Recombinant Fragment …
- 评论数: 1
CD73: an emerging checkpoint for cancer immunotherapy
The inhibition of CD73, in combination with immune checkpoint blockade, targeted therapy or conventional therapy, improves antitumor effects in numerous preclinical mouse models of …
- 某些结果已被删除